thanks
i short RHC a few years ago at around $68... it was overvalued
below is a history of CSL PE ratios at Sept quarter high price & Dec quarter low price
now today's CSL PE x 38 is based on forecast 30/6/18 earnings
it can be seen below the CSL PE ratio is at its historical maximum of Sept 2016 of 39, which fell to PE x 30 in Dec 2016
note: the $121 high occurred in July 2016. but in August & Sept, the price range was $99 to $109. in other words, the PE ratio of 39 was very short lived
![]()
- Forums
- ASX - By Stock
- CSL
- Ann: Half Year Results Analyst Presentation
Ann: Half Year Results Analyst Presentation, page-115
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$308.56 |
Change
1.960(0.64%) |
Mkt cap ! $149.1B |
Open | High | Low | Value | Volume |
$308.93 | $311.00 | $306.28 | $198.7M | 643.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 859 | $308.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$308.65 | 5 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 307.700 |
1 | 17 | 307.600 |
1 | 200 | 307.500 |
1 | 71 | 307.470 |
2 | 914 | 307.300 |
Price($) | Vol. | No. |
---|---|---|
308.650 | 5 | 1 |
308.700 | 60 | 1 |
308.720 | 914 | 1 |
308.730 | 71 | 1 |
308.750 | 100 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online